Summary
In order to determine the prevalence of hepatitis C virus (HCV) infection in the Black Sea region in Turkey, 287 serum samples taken from risk groups were investigated for anti-HCV antibodies using HCV EIA system. Anti-HCV antibodies were found to be positive in 51.2% of chronic haemodialysis patients, 20.6% of probable acute non-A, non-B hepatitis patients, 4% of patients who had multiple blood transfusions, 1.5% of the health personnel, while in new haemodialysis patients anti-HCV antibodies were not found.
Zusammenfassung
287 Serumproben von Personen aus Risikogruppen wurden mit dem HCV EIA System auf anti-HCV Antikörper untersucht, um die Prävalenz des Hepatitis C Virus in der Türkei in der Region am Schwarzen Meer zu bestimmen. Anti-HCV Antikörper fanden sich bei 51,2% der chronischen Hämodialyse-Patienten, bei 20,6% der Patienten mit wahrscheinlicher Non-A, Non-B- Hepatitis, 4% der Patienten, die multiple Bluttransfusionen erhalten hatten und 1,5% des Pflegepersonals. Bei Patienten, die neu in Hämodialyseprogramme aufgenommen wurden, fanden sich keine anti-HCV Antikörper.
This is a preview of subscription content, log in via an institution to check access.
References
Esteban, J. I., Esteban, R., Viladomiu, L., Lopez-Talavera, J. C., Gonzalez, A., Hernandez, J. M., Roget, M., Vargas, V., Genesca, J., Buti, M., Guardia, J., Houghto, M., Choo, Q.-L., Kuo, G. Hepatitis C virus antibodies among risk groups in Spain. Lancet ii (1989) 294–297.
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., Houghton, M. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359–362.
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., Tegtmeier, G. E., Bonino, F., Colombo, M., Lee, W.-S., Kuo, C., Berger, K., Shuster, J. R., Overby, L. R., Bradley, D. W., Houghton, M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244 (1989) 362–364.
Roggendorf, M., Deinhardt, F., Rasshofer, R., Eberle, J., Hopp, U., Moller, B., Zachoval, R., Papi, G., Schramm, W., Rommel, F. Antibodies to hepatitis C virus. Lancet ii (1989) 324–325.
Gilli, P., Moretti, M., Soffritti, S., Menini, C. Anti-HCV positive patients in dialysis units? Lancet 336 (1990) 243–244.
Zeldis, J. B., Depner, T. A., Kuramoto, I. K., Gish, R. G., Holland, P. V. The prevalence of hepatitis C virus antibodies among haemodialysis patients. Ann. Intern. Med. 112 (1990) 958–960.
Choo, Q.-L., Weiner, A. J., Overby, L. R., Kuo, G., Houghton, M., Bradley, D. W. Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br. Med. Bull. 46 (1990) 423–441.
Marchesi, D., Arici, C., Poletti, E., Mingardi, G., Minola, E., Mecca, G. Outbreak of non-A, non-B hepatitis in centre haemodialysis patients: a retrospective analysis. Nephrol. Dial. Transplant. 3 (1988) 795–799.
Laufs, R. Virology without virus? Infection 6 (1990) 325.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Köksal, I., Koç, F., Biberoğlu, K. et al. Hepatitis C virus antibodies among risk groups in Turkey. Infection 19, 228–229 (1991). https://doi.org/10.1007/BF01644950
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01644950